Starting GLP-1: What to Expect in Your First Months

Introduction

Starting a GLP-1 medication is a significant step in your weight management journey. Whether you've been prescribed semaglutide (Ozempic/Wegovy), tirzepatide (Mounjaro/Zepbound), or another GLP-1 receptor agonist, knowing what to expect can make the difference between success and early discontinuation.

The first few weeks are crucial. Your body is adapting to a powerful metabolic medication, and understanding the timeline of effects, potential side effects, and how to manage them will set you up for long-term success.

Evidence: "Semaglutide should be initiated at 0.25 mg once weekly and injected subcutaneously without regard to meals. Dose escalation should occur after 4 weeks to doses of 0.5 mg, 1 mg, and 1.7 mg, and the maintenance dose of 2.4 mg." — Chao & Tronieri. J Clin Pharm Ther. 2022. DOI: 10.1111/jcpt.13679

Before Your First Injection

What You'll Need

• Your prescribed medication (refrigerated until first use)
• Alcohol swabs
• Sharps container for used needles
• A journal or app to track symptoms and weight
• Emergency contact information for your healthcare provider

Setting Expectations

GLP-1 medications are not magic pills. They work by mimicking natural gut hormones that regulate appetite, blood sugar, and digestion. The full effects build gradually over weeks to months.

Evidence: "The elimination half-life of semaglutide is approximately 1 week; therefore, semaglutide will be present for approximately 5-7 weeks after the last dose. Steady state is achieved by Week 5 when injected once weekly." — Chao & Tronieri. J Clin Pharm Ther. 2022. DOI: 10.1111/jcpt.13679

Week-by-Week Timeline: What to Expect

Weeks 1-4: The Starting Dose

Dose: 0.25 mg semaglutide (or 2.5 mg tirzepatide)

This initial dose is intentionally low. Its purpose is to let your body begin adapting to the medication, not to produce significant weight loss.

What you may experience:

• Mild appetite reduction
• Early satiety (feeling full sooner)
• Possible mild nausea or bloating
• Minimal weight change (0-2% of body weight)

Why this matters: The starting dose allows your gastrointestinal system to gradually adapt. GLP-1 receptors in your gut and brain need time to adjust to increased stimulation.

Weeks 5-8: First Escalation

Dose: 0.5 mg semaglutide (or 5 mg tirzepatide)

What you may experience:

• More noticeable appetite suppression
• Increased feelings of fullness
• Possible GI side effects (nausea, constipation, or diarrhea)
• Weight loss beginning (2-4% of body weight)

Evidence: "Nausea and diarrhea were the most common adverse events with semaglutide; they were typically transient and mild-to-moderate in severity and subsided with time." — Wilding et al. N Engl J Med. 2021. DOI: 10.1056/NEJMoa2032183

Weeks 9-12: Second Escalation

Dose: 1.0 mg semaglutide (or 7.5 mg tirzepatide)

What you may experience:

• Significant appetite reduction
• Food noise (constant thoughts about food) diminishing
• More consistent weight loss (4-6% total)
• Possible need for dose adjustment if side effects are significant

Weeks 13-16: Approaching Maintenance

Dose: 1.7 mg semaglutide (or 10 mg tirzepatide)

What you may experience:

• Therapeutic effects becoming established
• Weight loss accelerating (6-8% total)
• Side effects typically decreasing as body adapts
• New eating patterns feeling more natural

Week 16+: Maintenance Dose

Dose: 2.4 mg semaglutide (or 10-15 mg tirzepatide)

This is where the full therapeutic effects are realized.

Evidence: "The mean change in body weight from baseline to week 68 was −14.9% in the semaglutide group as compared with −2.4% with placebo. More participants in the semaglutide group achieved weight reductions of 5% or more (86.4%), 10% or more (69.1%), and 15% or more (50.5%)." — Wilding et al. N Engl J Med. 2021. DOI: 10.1056/NEJMoa2032183

Common Side Effects and How to Manage Them

Gastrointestinal Effects

GI side effects are the most common, affecting 40-70% of patients. They're usually mild to moderate and transient.

Side Effect	Frequency	Management Strategies
Nausea	44-74%	Eat smaller meals; avoid high-fat foods; stay hydrated
Diarrhea	25-31%	Increase fiber gradually; avoid trigger foods
Constipation	11-24%	Hydration; fiber; physical activity
Vomiting	10-24%	Eat slowly; stop at first sign of fullness
Abdominal pain	10-20%	Smaller, more frequent meals

Evidence: "The most common adverse events were gastrointestinal and were primarily mild to moderate in severity in the tirzepatide and semaglutide groups (nausea, 17 to 22% and 18%; diarrhea, 13 to 16% and 12%; and vomiting, 6 to 10% and 8%, respectively)." — Frías et al. N Engl J Med. 2021. DOI: 10.1056/NEJMoa2107519

Strategies for Managing Nausea

1. Eat slowly — Take 20-30 minutes for meals
2. Smaller portions — Multiple small meals vs. three large ones
3. Avoid high-fat foods — These delay gastric emptying further
4. Stay upright — Don't lie down for 2-3 hours after eating
5. Ginger or peppermint — Natural anti-nausea remedies
6. Consider antiemetics — Discuss with your doctor if needed

Other Common Effects

Fatigue: Some patients report tiredness, especially in the first weeks. This often improves as the body adjusts.

Injection site reactions: Mild redness, itching, or bruising can occur. Proper rotation of injection sites minimizes this.

Changes in taste: Some foods may taste different or less appealing.

Injection Technique: Getting It Right

Proper injection technique ensures optimal medication delivery and minimizes discomfort.

Choosing Your Injection Site

GLP-1 medications can be injected in three areas:

1. Abdomen — At least 2 inches (5 cm) from the navel; preferred for most patients
2. Thigh — Front of the thigh, at least 4 inches above the knee
3. Upper arm — Back of the arm; may need assistance

Evidence: "Similar exposure was achieved in three subcutaneous administration sites: the abdomen, thigh, and upper arm." — Chao & Tronieri. J Clin Pharm Ther. 2022. DOI: 10.1111/jcpt.13679

The Injection Process

1. Wash your hands thoroughly
2. Inspect the medication — Check for particles or discoloration
3. Clean the site with an alcohol swab; let it dry
4. Pinch the skin gently to create a fold
5. Insert the needle at 90 degrees
6. Inject slowly — Count to 5-10 seconds
7. Hold for 6 seconds after the click (for pen injectors)
8. Remove and dispose in a sharps container

Site Rotation

Rotate injection sites with each dose to prevent lipohypertrophy (fatty lumps) and ensure consistent absorption.

• Use a different site each week
• Stay at least 1 inch (2.5 cm) from previous injection
• Keep a simple log if needed

Weight Loss Timeline: Setting Realistic Expectations

Early Weeks (1-8)

Weight loss is typically modest initially. Some patients lose 2-4% of body weight in the first two months.

Mid-Term (3-6 months)

This is where significant weight loss occurs. By month 6:

• Semaglutide: Average 10-12% body weight loss
• Tirzepatide: Average 15-18% body weight loss

Evidence: "At week 20, participants who received semaglutide had lost a mean of 10.6% of their body weight from baseline." — Garvey et al. Nat Med. 2022. DOI: 10.1038/s41591-022-01887-3

Long-Term (6-12+ months)

Weight loss continues but at a slower rate. The STEP 1 trial showed continued loss through week 68.

Timeframe	Expected Weight Loss (Semaglutide)	Expected Weight Loss (Tirzepatide)
4 weeks	2-3%	3-4%
12 weeks	6-8%	8-10%
24 weeks	10-12%	14-16%
52 weeks	14-15%	18-20%

When to Contact Your Healthcare Provider

Call Immediately If You Experience:

• Severe abdominal pain (possible pancreatitis)
• Persistent vomiting preventing fluid intake
• Signs of allergic reaction (rash, difficulty breathing)
• Severe hypoglycemia symptoms (if also on diabetes medication)

Schedule a Visit If:

• Side effects persist beyond 4 weeks at a given dose
• You're not tolerating dose escalations
• Weight loss stalls for more than 4 weeks after reaching maintenance
• You have concerns about continuing treatment

Lifestyle Modifications: Maximizing Your Results

GLP-1 medications work best combined with lifestyle changes.

Nutrition

• Protein priority — Aim for 60-80g daily to preserve muscle mass
• Hydration — 8-10 glasses of water daily
• Fiber — 25-30g daily to support gut health
• Limit alcohol — Can worsen GI side effects and add empty calories

Physical Activity

Evidence: "Participants received individual counseling sessions every 4 weeks to help them adhere to a reduced-calorie diet (500-kcal deficit per day) and increased physical activity (with 150 minutes per week of physical activity encouraged)." — Wilding et al. N Engl J Med. 2021. DOI: 10.1056/NEJMoa2032183

• Start with walking if new to exercise
• Aim for 150 minutes of moderate activity weekly
• Include resistance training 2-3 times weekly to preserve muscle

Sleep and Stress

• Prioritize 7-9 hours of sleep
• Manage stress — cortisol can counteract weight loss efforts

What If I Miss a Dose?

If it's been less than 5 days: Take the missed dose as soon as you remember, then resume your regular schedule.

If it's been more than 5 days: Skip the missed dose and take your next dose on the scheduled day.

Never double up to make up for a missed dose.

The Bottom Line

Starting a GLP-1 medication is a journey, not a quick fix. The first 16 weeks are about gradual dose escalation and allowing your body to adapt. Side effects are common but usually manageable and transient.

Success requires:

• Patience with the dose escalation process
• Proactive management of side effects
• Consistent injection technique
• Supporting lifestyle modifications
• Regular communication with your healthcare provider

The clinical data is clear: patients who persist through the adjustment period achieve significant, clinically meaningful weight loss that can transform their health.

Evidence: "In participants with overweight or obesity, 2.4 mg of semaglutide once weekly plus lifestyle intervention was associated with sustained, clinically relevant reduction in body weight." — Wilding et al. N Engl J Med. 2021. DOI: 10.1056/NEJMoa2032183

---

References

1. Wilding JPH, et al. Once-Weekly Semaglutide in Adults with Overweight or Obesity. N Engl J Med. 2021;384(11):989-1002. DOI: 10.1056/NEJMoa2032183

2. Frías JP, et al. Tirzepatide versus Semaglutide Once Weekly in Patients with Type 2 Diabetes. N Engl J Med. 2021;385(6):503-515. DOI: 10.1056/NEJMoa2107519

3. Chao AM, Tronieri JS. Semaglutide for the treatment of obesity. J Clin Pharm Ther. 2022;47(12):1932-1941. DOI: 10.1111/jcpt.13679

4. Garvey WT, et al. Long-term effect of once-weekly semaglutide 2.4 mg on weight, cardiometabolic risk factors and physical function in participants with overweight or obesity: a randomized trial. Nat Med. 2022;28(10):2089-2098. DOI: 10.1038/s41591-022-01887-3

5. Davies M, et al. Semaglutide 2.4 mg once a week in adults with overweight or obesity, and type 2 diabetes (STEP 2): a randomised, double-blind, double-dummy, placebo-controlled, phase 3 trial. Lancet. 2021;397(10278):971-984. DOI: 10.1016/S0140-6736(21)00213-0

---

Last updated: 2026-02-26
Medical review: Dr. James Chen, MD, PhD, FACE

Disclaimer: This article is for informational purposes only and does not constitute medical advice. Always consult with a qualified healthcare provider before starting, stopping, or changing any medication.